Posts Tagged ‘Mid Stage’

Novartis Drug Combo Cuts Pancreatic Tumour Size

24th June 2009 by admin No Comments

A combination of two drugs from Novartis AG (NOVN.VX) cut the size of pancreatic neuroendocrine tumours in more than 80 percent of patients in a mid-stage study, the Swiss group said on Wednesday. Patients who received a once-daily pill Afinitor in combination with Sandostatin LAR had no progression in their disease for a median of [...]

Medarex Shares Up As Prostate Cancer Drug Shows Promise

24th June 2009 by admin 2 Comments

Shares of Medarex Inc (MEDX.O) rose as much as 22 percent Monday on a Mayo Clinic report that two prostate cancer patients became cancer-free after being treated with the company’s experimental drug, ipilimumab, in combination with other therapies and surgery.
On Friday, the Mayo Clinic said both patients experienced reduction in levels of a protein called [...]